{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:47:09Z","timestamp":1760143629998,"version":"build-2065373602"},"reference-count":53,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation for Science and Technology (FCT)","award":["PEst-C\/SAU\/LA0001\/2013-2014","UIDB\/04539\/2020","UIDP\/04539\/2020","LA\/P\/0058\/2020"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0001\/2013-2014","UIDB\/04539\/2020","UIDP\/04539\/2020","LA\/P\/0058\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive and multifactorial disease that significantly compromises the lives of millions of people worldwide [...]<\/jats:p>","DOI":"10.3390\/biomedicines12030478","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:23:10Z","timestamp":1708489390000},"page":"478","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Special Issue \u201cAlzheimer\u2019s Disease\u2014115 Years after Its Discovery\u201d"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9866-933X","authenticated-orcid":false,"given":"Susana","family":"Cardoso","sequence":"first","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Institute for Interdisciplinary Research, University of Coimbra, 3030-789 Coimbra, Portugal"}]},{"given":"Cristina","family":"Carvalho","sequence":"additional","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Institute for Interdisciplinary Research, University of Coimbra, 3030-789 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-2564","authenticated-orcid":false,"given":"S\u00f3nia C.","family":"Correia","sequence":"additional","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Institute for Interdisciplinary Research, University of Coimbra, 3030-789 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Garcia-Morales, V., Gonzalez-Acedo, A., Melguizo-Rodriguez, L., Pardo-Moreno, T., Costela-Ruiz, V.J., Montiel-Troya, M., and Ramos-Rodriguez, J.J. (2021). Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer\u2019s Disease. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121910"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mankhong, S., Kim, S., Lee, S., Kwak, H.B., Park, D.H., Joa, K.L., and Kang, J.H. (2022). Development of Alzheimer\u2019s Disease Biomarkers: From CSF- to Blood-Based Biomarkers. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040850"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Phan, L.M.T., and Cho, S. (2022). Fluorescent Aptasensor and Colorimetric Aptablot for p-tau231 Detection: Toward Early Diagnosis of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010093"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ma, Y., Brettschneider, J., and Collingwood, J.F. (2022). A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.37766\/inplasy2022.7.0020"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/brain\/awac407","article-title":"Brain-derived tau: A novel blood-based biomarker for Alzheimer\u2019s disease-type neurodegeneration","volume":"146","author":"Turton","year":"2023","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jullienne, A., Trinh, M.V., and Obenaus, A. (2022). Neuroimaging of Mouse Models of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020305"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Balaji, P., Chaurasia, M.A., Bilfaqih, S.M., Muniasamy, A., and Alsid, L.E.G. (2023). Hybridized Deep Learning Approach for Detecting Alzheimer\u2019s Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010149"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, J., Jeong, M., Stiles, W.R., and Choi, H.S. (2022). Neuroimaging Modalities in Alzheimer\u2019s Disease: Diagnosis and Clinical Features. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116079"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chiarelli, A.M., Perpetuini, D., Croce, P., Filippini, C., Cardone, D., Rotunno, L., Anzoletti, N., Zito, M., Zappasodi, F., and Merla, A. (2021). Evidence of Neurovascular Un-Coupling in Mild Alzheimer\u2019s Disease through Multimodal EEG-fNIRS and Multivariate Analysis of Resting-State Data. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040337"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ncl.2023.01.001","article-title":"Sex Differences in Alzheimer\u2019s Disease","volume":"41","author":"Aggarwal","year":"2023","journal-title":"Neurol. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41467-023-38374-z","article-title":"Functional variants identify sex-specific genes and pathways in Alzheimer\u2019s Disease","volume":"14","author":"Bourquard","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Silva-Spinola, A., Baldeiras, I., Arrais, J.P., and Santana, I. (2022). The Road to Personalized Medicine in Alzheimer\u2019s Disease: The Use of Artificial Intelligence. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020315"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rao, R.V., Kumar, S., Gregory, J., Coward, C., Okada, S., Lipa, W., Kelly, L., and Bredesen, D.E. (2021). ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101348"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/JAD-150975","article-title":"Spatial Memory Impairment is Associated with Intraneural Amyloid-beta Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"51","author":"Morin","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Leung, H.W., Foo, G., and VanDongen, A. (2022). Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081946"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Caballero, E., Hernando-Perez, E., Tapias, V., Calvo-Rodriguez, M., Villalobos, C., and Nunez, L. (2022). Amyloid Beta Oligomers-Induced Ca(2+) Entry Pathways: Role of Neuronal Networks, NMDA Receptors and Amyloid Channel Formation. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051153"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Antequera, D., Carrero, L., Cunha Alves, V., Ferrer, I., Hernandez-Gallego, J., Municio, C., and Carro, E. (2022). Differentially Aquaporin 5 Expression in Submandibular Glands and Cerebral Cortex in Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071645"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Municio, C., Carrero, L., Antequera, D., and Carro, E. (2023). Choroid Plexus Aquaporins in CSF Homeostasis and the Glymphatic System: Their Relevance for Alzheimer\u2019s Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010878"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain Abeta accumulation and memory deficits","volume":"10","author":"Xu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yamada, K. (2023). Multifaceted Roles of Aquaporins in the Pathogenesis of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076528"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Giao, T., Teixeira, T., Almeida, M.R., and Cardoso, I. (2022). Choroid Plexus in Alzheimer\u2019s Disease-The Current State of Knowledge. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020224"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e030780","DOI":"10.1161\/JAHA.123.030780","article-title":"Cardiovascular Disease and Alzheimer\u2019s Disease: The Heart-Brain Axis","volume":"12","author":"Saeed","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lee, T., Lee, H., and Alzheimer\u2019s Disease Neuroimaging Initiative (2021). Identification of Disease-Related Genes That Are Common between Alzheimer\u2019s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111525"},{"key":"ref_25","first-page":"e48430","article-title":"A Comprehensive Review of Modifiable Cardiovascular Risk Factors and Genetic Influences in Dementia Prevention","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1212\/WNL.0000000000013174","article-title":"Sex Differences in the Association between Midlife Cardiovascular Conditions or Risk Factors with Midlife Cognitive Decline","volume":"98","author":"Huo","year":"2022","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Jullienne, A., Quan, R., Szu, J.I., Trinh, M.V., Behringer, E.J., and Obenaus, A. (2022). Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081967"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/febs.15571","article-title":"Microbiota modulation as preventative and therapeutic approach in Alzheimer\u2019s disease","volume":"288","author":"Bonfili","year":"2021","journal-title":"FEBS J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00632-19","DOI":"10.1128\/mBio.00632-19","article-title":"Alzheimer\u2019s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway","volume":"10","author":"Haran","year":"2019","journal-title":"mBio"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1093\/brain\/awad303","article-title":"Microbiota from Alzheimer\u2019s patients induce deficits in cognition and hippocampal neurogenesis","volume":"146","author":"Grabrucker","year":"2023","journal-title":"Brain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","article-title":"Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice","volume":"9","author":"Sun","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Marcos Pasero, H., Garcia Tejedor, A., Gimenez-Bastida, J.A., and Laparra Llopis, J.M. (2022). Modifiable Innate Biology within the Gut-Brain Axis for Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092098"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/glia.24343","article-title":"Interactions of glial cells with neuronal synapses, from astrocytes to microglia and oligodendrocyte lineage cells","volume":"71","author":"Liu","year":"2023","journal-title":"Glia"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rudnitskaya, E.A., Kozlova, T.A., Burnyasheva, A.O., Stefanova, N.A., and Kolosova, N.G. (2021). Glia Not Neurons: Uncovering Brain Dysmaturation in a Rat Model of Alzheimer\u2019s Disease. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070823"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Munoz Herrera, O.M., and Zivkovic, A.M. (2022). Microglia and Cholesterol Handling: Implications for Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123105"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hong, B.V., Zheng, J., Agus, J.K., Tang, X., Lebrilla, C.B., Jin, L.W., Maezawa, I., Erickson, K., Harvey, D.J., and DeCarli, C.S. (2022). High-Density Lipoprotein Changes in Alzheimer\u2019s Disease Are APOE Genotype-Specific. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071495"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/alz.12649","article-title":"The small HDL particle hypothesis of Alzheimer\u2019s disease","volume":"19","author":"Martinez","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Umeda, T., Uekado, R., Shigemori, K., Eguchi, H., and Tomiyama, T. (2022). Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020297"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Trobec, T., Sepcic, K., Zuzek, M.C., Kladnik, J., Podjed, N., Cardoso Pascoa, C., Turel, I., and Frangez, R. (2021). Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes. Biomedicines, 9.","DOI":"10.3390\/biomedicines9091243"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chowdhury, M.R., Jin, H.K., and Bae, J.S. (2022). Diverse Roles of Ceramide in the Progression and Pathogenesis of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081956"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Vicente-Zurdo, D., Rosales-Conrado, N., Leon-Gonzalez, M.E., Brunetti, L., Piemontese, L., Pereira-Santos, A.R., Cardoso, S.M., Madrid, Y., Chaves, S., and Santos, M.A. (2022). Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071510"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3389\/fnins.2020.00762","article-title":"Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer\u2019s Disease","volume":"14","author":"Iannucci","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Grossmann, K. (2022). Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081890"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cho, H., and Hah, J.M. (2021). A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer\u2019s Disease: Investigating Structure through Docking Studies. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101431"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e1019","DOI":"10.1038\/cddis.2013.559","article-title":"c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo","volume":"5","author":"Sclip","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_47","first-page":"1524","article-title":"JNK Activation in Alzheimer\u2019s Disease Is Driven by Amyloid beta and Is Associated with Tau Pathology","volume":"14","author":"Solas","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"114917","DOI":"10.1016\/j.ejmech.2022.114917","article-title":"Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases","volume":"245","author":"Jun","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"154714","DOI":"10.1016\/j.phymed.2023.154714","article-title":"Magnoflorine improves cognitive deficits and pathology of Alzheimer\u2019s disease via inhibiting of JNK signaling pathway","volume":"112","author":"Zhong","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: Experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41598-021-83892-9","article-title":"Exploring the conservation of Alzheimer-related pathways between H. sapiens and C. elegans: A network alignment approach","volume":"11","author":"Apostolakou","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Alvarez, J., Alvarez-Illera, P., Santo-Domingo, J., Fonteriz, R.I., and Montero, M. (2022). Modeling Alzheimer\u2019s Disease in Caenorhabditis elegans. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020288"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e12114","DOI":"10.1002\/trc2.12114","article-title":"Translational animal models for Alzheimer\u2019s disease: An Alzheimer\u2019s Association Business Consortium Think Tank","volume":"6","author":"Vitek","year":"2020","journal-title":"Alzheimers Dement."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/3\/478\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:02:07Z","timestamp":1760104927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/3\/478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["biomedicines12030478"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12030478","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2024,2,21]]}}}